NEWS
View news from our Featured Companies.
SenesTech Expands E-Commerce Presence with Evolve Rodent Birth Control™ Now Available on TractorSupply.com
PHOENIX, Feb. 10, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech"), a pioneer in humane rodent pest control solutions, is pleased to announce that its Evolve™ Rodent Birth Control product line is now available for purchase on TractorSupply.com. This expansion...
S&W Seed Company to Report Second Quarter Fiscal Year 2025 Financial Results on Thursday, February 13, 2025
Conference call to be conducted on Thursday, February 13, 2025, at 11:00 a.m. ET LONGMONT, Colo., Feb. 6, 2025 -- S&W Seed Company (Nasdaq: SANW) will report financial results for its second quarter fiscal year 2025, ended December 31, 2024, on Thursday, February...
Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025
DENVER, CO / ACCESS Newswire / February 5, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its second quarter of fiscal...
SenesTech Expands Global Footprint for Evolve Rodent Birth Control™: Signs Letter of Intent with SMark to Enter Indian Rodent Pest Control Market
PHOENIX, Feb. 4, 2025 -- SenesTech, Inc. (Nasdaq: SNES), a pioneer in humane pest control solutions, is pleased to announce its plans to enter the Indian rodent pest control market through a partnership with SMark, a well-established distributor based in India. The...
Dror Ortho-Design Partners with Aran R&D to Advance Production
JERUSALEM, Feb. 04, 2025 -- Dror Ortho-Design, Inc. ("Dror" or the "Company") (OTC PINK: DROR), a pioneer in AI-powered orthodontic solutions, today announced a strategic partnership with Aran Research & Development, a premier Israel-based medical device developer...
Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
CUPERTINO, Calif., Feb. 04, 2025 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
ARIANNE PHOSPHATE TO PRESENT AT THE CANADIAN GOVERNMENT FORUM ON CRITICAL MINERALS
DAN: TSX-V (Canada)JE9N: FSE (Germany)DRRSF: OTCQX (USA) SAGUENAY, QC, Feb. 3, 2025 /CNW/ - Arianne Phosphate (the "Company" or "Arianne") (TSXV: DAN) (OTCQX: DRRSF) (FRANKFURT: JE9N), a development-stage phosphate mining company, advancing the Lac à Paul project...
LiqTech Announces Appointment of David Kowalczyk as Chief Financial and Operating Officer
BALLERUP, Denmark, Jan. 31, 2025 -- LiqTech International, Inc. (NASDAQ: LIQT), a clean technology company specializing in highly advanced filtration products and systems, today announced the appointment of David Kowalczyk as Chief Financial and Chief Operating...
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025
WINTER SPRINGS, Fla., Jan. 30, 2025 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, February 13, 2025. Iradimed management will host a conference call...
Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance
- Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market- Targeting Q1 2026 for expected clearance of the MODD1 in the E.U. SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 30, 2025...
Reviva to Participate in the 2025 BIO CEO & Investor Conference
CUPERTINO, Calif., Jan. 30, 2025 -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS),...
PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
PETACH TIKVA, Israel, Jan. 30, 2025 -- PolyPid Ltd. (Nasdaq: PYPD), ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company's management will present at the Oppenheimer 35th Annual Healthcare...
PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025
PETACH TIKVA, Israel, Jan. 29, 2025 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its fourth quarter and full-year 2024 financial results and...
Precision Optics Launches Revolutionary Unity Imaging Platform
GARDNER, Mass., Jan. 28, 2025 -- Precision Optics Corporation (Nasdaq: POCI), a global leader in the design and development of optical components and systems for advanced medical, industrial, and defense/aerospace applications, is pleased to announce the launch of the...
UPDATE – NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States
CARMEL, Ind., Jan. 21, 2025 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced medical...
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
GAITHERSBURG, Md., Jan. 21, 2025 -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT),...
Baltimore Adopts Evolve™ Rodent Birth Control for Integrated Pest Management Targeting Rodent Overpopulation
Identifies Population Control as a Humane, Effective Solution for Winning the War Against Rats PHOENIX, Jan. 21, 2025 -- SenesTech, Inc. (NASDAQ: SNES), a leader in innovative pest control solutions, is pleased to announce that the City of Baltimore has begun...
ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses
PORTLAND, Maine, Jan. 16, 2025 -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy...
Zoomd Technologies to Participate in the 11th annual AlphaNorth Capital Event
TORONTO, Jan. 15, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing technology (MarTech) user-acquisition and engagement platform, is pleased to announce the...
Zoomd’s Director and former CEO, Ofer Eitan, Establishes Automatic Share Disposition Plan
TORONTO, Jan. 14, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly-owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), the marketing tech (MarTech) user-acquisition and engagement platform, announced today that Ofer Eitan, one...
Jewett-Cameron Reports Fiscal 2025 First Quarter Operational and Financial Results
NORTH PLAINS, Ore., Jan. 14, 2025 -- Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced operational and financial results for the fiscal 2025 first quarter for the period ended...
Bug Off Pest Control Center of New York City to Supply New York City with Evolve™
PHOENIX, Jan. 14, 2025 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in humane pest control solutions, is pleased to announce that Evolve™ Rodent Birth Control, our innovative rodent control product, will soon be available through...
S&W Seed Company Commencing Strategic Alternatives Review Process
LONGMONT, Colo., Jan. 13, 2025 -- S&W Seed Company (Nasdaq: SANW) ("S&W Seed" or the "Company"), today announced that its Board of Directors (the "Board") of the Company is commencing a process to explore and evaluate various strategic alternatives that may be...
NeurAxis Inc. Issues Letter to Shareholders
CARMEL, Ind., Jan. 13, 2025 -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that CEO...
Zoomd Expands Global Reach with New Client Partnerships Across Multiple Industries
TORONTO, Jan. 13, 2025 -- Zoomd Technologies Ltd. (TSXV: ZOMD) (OTC: ZMDTF) and its wholly owned subsidiary Zoomd Ltd. (collectively, "Zoomd" or the "Company"), a leading marketing tech (MarTech) user-acquisition and engagement platform, proudly announce the...